The role of additional chemotherapy prior to autologous HCT in patients with relapse/refractory DLBCL in partial remission-A retrospective multicenter study.

Liat Shargian-AlonOdelia AmitHanna BernstineRonit GurionAnat Gafter-GviliUri RozovskiOren PasvolskyGalit PeretsNetanel A HorowitzJabour HallounChava PerryIrit AviviPia RaananiMoshe YeshurunRon Ram

Published in: European journal of haematology (2022)

Referring patients with chemotherapy-sensitive disease in PR directly to HCT is associated with better OS compared to those receiving additional lines of treatment.

Keyphrases

locally advanced
cell cycle arrest
diffuse large b cell lymphoma
bone marrow
disease activity
stem cells
squamous cell carcinoma
rheumatoid arthritis
rectal cancer
cell death
ulcerative colitis
signaling pathway
smoking cessation